The direct costs to the NHS of discontinuing and switching prescriptions for hypertension

@article{Hughes1998TheDC,
  title={The direct costs to the NHS of discontinuing and switching prescriptions for hypertension},
  author={Dafydd Hughes and Alistair McGuire},
  journal={Journal of Human Hypertension},
  year={1998},
  volume={12},
  pages={533-537}
}
There is much evidence to suggest that the treatment of hypertension reduces the risk of cardiovascular diseases and that it is cost-effective in most patients. However, the effectiveness of treatment relies on compliance and maintenance of treatment. Each pharmacological agent differs in terms of side effects. The existence of side effects can result in poor compliance and switching between treatments. A number of studies have reported high discontinuation rates for anti-hypertensive therapies… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Pharmacoeconomics of Hypertension Management

PharmacoEconomics • 2012
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…